Sign in
4

Changes in Ownership

Inhibitor Therapeutics, Inc. Filed Acc 0000899243-18-007585

Options or other derivatives

  • Director acquired 329,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Watson W. Mark Director 2018-03-13 Grant or award · Common Stock Option +253,000 253,000 D
Watson W. Mark Director 2018-03-13 Grant or award · Common Stock Option +76,000 76,000 D
Loading xslF345X03/doc4.xml…